Form 8-K ENANTA PHARMACEUTICALS For: Aug 11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Enanta Pharm (ENTA) Posts Mixed Q3 Results
August 11, 2014 9:23 AM EDTEnanta Pharm (NASDAQ: ENTA) reported Q3 EPS of $2.61, $0.94 better than the analyst estimate of $1.67. Revenue for the quarter came in at $42.1 million versus the consensus estimate of $40.83 million.
For earnings history and earnings-related data on Enanta Pharm (ENTA) click here.
... More